Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Title

Author

Year

A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.

Olaosebikan, R; Ernest, K; BOJANG, K; Mokuolu, O; REHMAN, AM; Affara, M; NWAKANMA, D; Kiechel, J-R; Ogunkunle, T; Olagunju, T; Murtala, R; Omefe, P; Lambe, T; Bello, S; Ibrahim, O; Olorunsola, B; Ojuawo, A; GREENWOOD, B; MILLIGAN, P;

2015

The Journal of infectious diseases, (2015).212 4 10.1093/infdis/jiv093.

Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir.

Thanh, PV; Van Hong, N; Van Van, N; Van Malderen, C; Obsomer, V; Rosanas-Urgell, A; Grietens, KP; Xa, NX; Bancone, G; Chowwiwat, N; Duong, TT; D'ALESSANDRO, U; Speybroeck, N; ERHART, A;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0601-y.

African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.

Manjurano, A; Sepulveda, N; NADJM, B; Mtove, G; Wangai, H; Maxwell, C; Olomi, R; REYBURN, H; RILEY, EM; DRAKELEY, CJ; CLARK, TG; MalariaGEN Consortium,;

2015

PLoS genetics, (2015).11 2 10.1371/journal.pgen.1004960.

Situating the trovan trial with the use of experimental ebola therapies is like comparing an apple with an orange.

AFOLABI, MO;

2015

Journal of bioethical inquiry, (2015).12 1 10.1007/s11673-015-9619-7.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens.

Kapisi, J; Bigira, V; Clark, T; Kinara, S; Mwangwa, F; ACHAN, J; Kamya, M; SOREMEKUN, S; Dorsey, G;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0583-9.

Intrapericardial rupture of a mitral subannular aneurysm: A case report and review of the literature.

Diop, IB; Leye, M; Diallo, AD; Sarr, EH M; Manga, SJ; Diene, LL; JOBE, M;

2015

Annales de cardiologie et d'angeiologie, (2015).65 2 10.1016/j.ancard.2015.01.013.

Microbiota that affect risk for shigellosis in children in low-income countries.

Lindsay, B; OUNDO, J; Hossain, MA; ANTONIO, M; Tamboura, B; Walker, AW; Paulson, JN; Parkhill, J; Omore, R; Faruque, AS G; Das, SK; IKUMAPAYI, UN; Adeyemi, M; Sanogo, D; Saha, D; Sow, S; Farag, TH; Nasrin, D; Li, S; Panchalingam, S; Levine, MM; Kotloff, K; Magder, LS; Hungerford, L; Sommerfelt, H; ... Stine, OC.

2015

Emerging infectious diseases, (2015).21 2 10.3201/eid2101.140795.

Superior vena cava syndrome revealing a Behçet's disease.

Sarr, SA; Fall, PD; Mboup, MC; Dia, K; Bodian, M; JOBE, M;

2015

Thrombosis journal, (2015).13, 10.1186/s12959-015-0039-z.

Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

Njai, HF; Shimakawa, Y; Sanneh, B; Ferguson, L; NDOW, G; Mendy, M; Sow, A; Lo, G; Toure-Kane, C; Tanaka, J; Taal, M; D'ALESSANDRO, U; Njie, R; Thursz, M; Lemoine, M;

2015

Journal of clinical microbiology, (2015).53 4 10.1128/jcm.02980-14.

KIR3DL1*0250102: a novel three-domain KIR subtype identified in West Africa.

Yindom, L-M; DE SILVA, TI; Rowland-Jones, SL;

2015

Tissue antigens, (2015).85 2 10.1111/tan.12501.